Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.1 (
alkaline phosphatase
)
47,916
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The concentration of the toxic mediators histamine and serotonin as well as the activity of lactate-dehydrogenase and
alkaline phosphatase
in banked blood increase significantly during storage. After initial addition of
Aprotinin
to ACD-Blood the level of these substances remained almost in normal range. The influence of these toxic mediators on the development of shock lung is discussed.
...
PMID:[Aprotinin-ACD-blood. II. The effect of aprotinin on the release of cellular mediators and enzymes in banked blood (author's transl)]. 617 8
Prostaglandin E2 (PGE2)-like activity was measured in osteonecrotic femoral heads caused by high doses of methyl prednisolone acetate in rabbits. Serum levels of cholesterol, total lipids, free fatty acids,
alkaline phosphatase
, SGOT and lipase were also determined. There were increases in local tissue PGE2-like activity, serum cholesterol, total lipid and free fatty acid levels in rabbits with steroid-induced osteonecrosis as compared to the controls. The rabbits given aprotinin together with the steroid showed significant decreases in serum cholesterol and lipid levels coupled with a marked increase in the local PGE2-like activity.
Aprotinin
prevented osteonecrosis induced by steroids. The results are discussed in the light of the relevant literature.
...
PMID:Isolation of prostaglandin E2-like material from osteonecrosis induced by steroids and its prevention by kallikrein-inhibitor, aprotinin. An experimental study in rabbits. 620 27